News > HCQ ineffective as preventive antiviral against Covid-19
HCQ ineffective as preventive antiviral against Covid-19
Business Standard | 18/08/2020 03:50 PM | Click to read full article
New research adds to the growing body of evidence that how the famous anti-malarial drug hydroxychloroquine (HCQ) is not a possible defense against Covid-19
The study, found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population. Treatment with HCQ early in the disease or for mild cases is still under review.